The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Open accessAbstract
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections and hospitalization in infants under 1 year of age and there is currently no market-approved vaccine available. For protection against infection, young children mainly depend on their innate immune system and maternal antibodies. Traditionally, antibody-mediated protection against viral infections is thought to be mediated by direct binding of antibodies to viral particles, resulting in virus neutralization. However, in the case of RSV, virus neutralization titers do not provide an adequate correlate of protection. The current lack of understanding of the mechanisms by which antibodies can protect against RSV infection and disease or, alternatively, contribute to disease severity, hampers the design of safe and effective vaccines against this virus. Importantly, neutralization is only one of many mechanisms by which antibodies can interfere with viral infection. Antibodies consist of two structural regions: a variable fragment (Fab) that mediates antigen binding and a constant fragment (Fc) that mediates downstream effector functions via its interaction with Fc-receptors on (innate) immune cells or with C1q, the recognition molecule of the complement system. The interaction with Fc-receptors can lead to killing of virus-infected cells through a variety of immune effector mechanisms, including antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). Antibody-mediated complement activation may lead to complement-dependent cytotoxicity (CDC). In addition, both Fc-receptor interactions and complement activation can exert a broad range of immunomodulatory functions. Recent studies have emphasized the importance of Fc-mediated antibody effector functions in both protection and pathogenesis for various infectious agents. In this review article, we aim to provide a comprehensive overview of the current knowledge on Fc-mediated antibody effector functions in the context of RSV infection, discuss their potential role in establishing the balance between protection and pathogenesis, and point out important gaps in our understanding of these processes. Furthermore, we elaborate on the regulation of these effector functions on both the cellular and humoral side. Finally, we discuss the implications of Fc-mediated antibody effector functions for the rational design of safe and effective vaccines and monoclonal antibody therapies against RSV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
Shi, T., McAllister, D. A., O'Brien, K. L., Simoes, E. A. F., Madhi, S. A., Gessner, B. D., Polack, F. P., Balsells, E., Acacio, S., Aguayo, C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30938-8 · Cited by 2,371
The Burden of Respiratory Syncytial Virus Infection in Young Children
Hall, C. B., Weinberg, G. A., Iwane, M. K., Blumkin, A. K., Edwards, K. M., Staat, M. A., Auinger, P., Griffin, M. R., Poehling, K. A., Erdman, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804877 · Cited by 2,246
Scott, A. M., Wolchok, J. D., & Old, L. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3236 · Cited by 2,160
The IMpact-RSV Study Group (1998) · Pediatrics · doi:10.1542/peds.102.3.531 · Cited by 1,961
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus
Glezen, W. P. (1986) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1986.02140200053026 · Cited by 1,527
Bruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., & Daëron, M. (2009) · Blood · doi:10.1182/blood-2008-09-179754 · Cited by 1,479
Antibody-dependent enhancement of severe dengue disease in humans
Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G., Gordon, A., Balmaseda, A., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,205
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
Stevens, T. L., Bossie, A., Sanders, V. M., Fernandez-Botran, R., Coffman, R. L., Mosmann, T. R., & Vitetta, E. S. (1988) · Nature · doi:10.1038/334255a0 · Cited by 933 · cited 1×
“In mice, neonatal IgG responses to RSV infection are significantly skewed toward mIgG1 (homologous to human IgG4), indicating a Th2 bias (156), whereas primary infection in adult mice leads to a balanced mIgG2a/mIgG1 response (homologous to human IgG1/IgG4) (157).”
BackgroundFc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
McLellan, J. S., Chen, M., Leung, S., Graepel, K. W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013) · Science · doi:10.1126/science.1234914 · Cited by 883
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Diebolder, C. A., Beurskens, F. J., de Jong, R. N., Koning, R. I., Strumane, K., Lindorfer, M. A., Voorhorst, M., Ugurlar, D., Rosati, S., Heck, A. J. R., et al. (2014) · Science · doi:10.1126/science.1248943 · Cited by 796
Koene, H. R., Kleijer, M., Algra, J., Roos, D., E.G.Kr. von dem Borne, A., & de Haas, M. (1997) · Blood · doi:10.1182/blood.v90.3.1109 · Cited by 794
Ferrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A. C., Stihle, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108455108 · Cited by 770
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
Spontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis
Bolland, S., & Ravetch, J. V. (2000) · Immunity · doi:10.1016/s1074-7613(00)00027-3 · Cited by 752
DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749
Activation of NK cell cytotoxicity
Smyth, M. J., Cretney, E., Kelly, J. M., Westwood, J. A., Street, S. E. A., Yagita, H., Takeda, K., Dommelen, S. L. H. V., Degli-Esposti, M. A., & Hayakawa, Y. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.034 · Cited by 714
Wu, J., Edberg, J. C., Redecha, P. B., Bansal, V, Guyre, P. M., Coleman, K., Salmon, J. E., & Kimberly, R. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119616 · Cited by 711
Brüggemann, M., Williams, G. T., Bindon, C. I., Clark, M. R., Walker, M. R., Jefferis, R., Waldmann, H., & Neuberger, M. S. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1351 · Cited by 607
A Functional Role for Antibodies in Tuberculosis
Lu, L. L., Chung, A. W., Rosebrock, T. R., Ghebremichael, M., Yu, W. H., Grace, P. S., Schoen, M. K., Tafesse, F., Martin, C., Leung, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.072 · Cited by 571
Welliver, R. C., Wong, D. T., Sun, M., Middleton, E., Vaughan, R. S., & Ogra, P. L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110083051501 · Cited by 529
Anti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Delgado, M. F., Coviello, S., Monsalvo, A. C., Melendi, G. A., Hernandez, J. Z., Batalle, J. P., Diaz, L., Trento, A., Chang, H.-Y., Mitzner, W., et al. (2009) · Nature Medicine · doi:10.1038/nm.1894 · Cited by 500
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Bournazos, S., Klein, F., Pietzsch, J., Seaman, M. S., Nussenzweig, M. C., & Ravetch, J. V. (2014) · Cell · doi:10.1016/j.cell.2014.08.023 · Cited by 493
Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review
Maverakis, E., Kim, K., Shimoda, M., Gershwin, M. E., Patel, F., Wilken, R., Raychaudhuri, S., Ruhaak, L. R., & Lebrilla, C. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.12.002 · Cited by 459
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
Tripp, R. A., Jones, L. P., Haynes, L. M., Zheng, H., Murphy, P. M., & Anderson, L. J. (2001) · Nature Immunology · doi:10.1038/90675 · Cited by 456
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Ngwuta, J. O., Chen, M., Modjarrad, K., Joyce, M. G., Kanekiyo, M., Kumar, A., Yassine, H. M., Moin, S. M., Killikelly, A. M., Chuang, G.-Y., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4241 · Cited by 431
Welliver, T. P., Garofalo, R. P., Hosakote, Y., Hintz, K. H., Avendano, L., Sanchez, K., Velozo, L., Jafri, H., Chavez‐Bueno, S., Ogra, P. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512615 · Cited by 425
Mellor, J. D., Brown, M. P., Irving, H. R., Zalcberg, J. R., & Dobrovic, A. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-1 · Cited by 415
Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S., & Mosser, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70166-3 · Cited by 409
Chung, A. W., Ghebremichael, M., Robinson, H., Brown, E., Choi, I., Lane, S., Dugast, A.-S., Schoen, M. K., Rolland, M., Suscovich, T. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007736 · Cited by 406
A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease
Polack, F. P., Teng, M. N., L.Collins, P., Prince, G. A., Exner, M., Regele, H., Lirman, D. D., Rabold, R., Hoffman, S. J., Karp, C. L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020781 · Cited by 400
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
Boruchov, A. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24772 · Cited by 377
Bonsignori, M., Pollara, J., Moody, M. A., Alpert, M. D., Chen, X., Hwang, K.-K., Gilbert, P. B., Huang, Y., Gurley, T. C., Kozink, D. M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.01023-12 · Cited by 375
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
Wang, T. T., Sewatanon, J., Memoli, M. J., Wrammert, J., Bournazos, S., Bhaumik, S. K., Pinsky, B. A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., et al. (2017) · Science · doi:10.1126/science.aai8128 · Cited by 369
Everard, M. L., Swarbrick, A., Wrightham, M., McIntyre, J., Dunkley, C., James, P. D., Sewell, H. F., & Milner, A. D. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.5.428 · Cited by 365
Dekkers, G., Treffers, L., Plomp, R., Bentlage, A. E. H., de Boer, M., Koeleman, C. A. M., Lissenberg-Thunnissen, S. N., Visser, R., Brouwer, M., Mok, J. Y., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00877 · Cited by 356
Barouch, D. H., Stephenson, K. E., Borducchi, E. N., Smith, K., Stanley, K., McNally, A. G., Liu, J., Abbink, P., Maxfield, L. F., Seaman, M. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.061 · Cited by 342
Lambotte, O., Ferrari, G., Moog, C., Yates, N. L., Liao, H.-X., Parks, R. J., Hicks, C. B., Owzar, K., Tomaras, G. D., Montefiori, D. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328329f97d · Cited by 342
The Immunoregulatory Roles of Antibody Glycosylation
Jennewein, M. F., & Alter, G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.02.004 · Cited by 323
Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., & Metzger, D. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7381 · Cited by 319
Molecular basis for a polymorphism of human Fc gamma receptor II (CD32).
Warmerdam, P. A., van de Winkel, J. G., Gosselin, E. J., & Capel, P. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.19 · Cited by 298
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
Barouch, D. H., Alter, G., Broge, T., Linde, C., Ackerman, M. E., Brown, E. P., Borducchi, E. N., Smith, K. M., Nkolola, J. P., Liu, J., et al. (2015) · Science · doi:10.1126/science.aab3886 · Cited by 297
Skowronski, D. M., De Serres, G., Crowcroft, N. S., Janjua, N. Z., Boulianne, N., Hottes, T. S., Rosella, L. C., Dickinson, J. A., Gilca, R., Sethi, P., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000258 · Cited by 297
Janssen, R., Bont, L., Siezen, C. L. E., Hodemaekers, H. M., Ermers, M. J., Doornbos, G., Slot, R. V. ’., Wijmenga, C., Goeman, J. J., Kimpen, J. L. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/520886 · Cited by 293
Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection
Openshaw, P. J. M., & Tregoning, J. S. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.541-555.2005 · Cited by 292
Ichikawa, A., Kuba, K., Morita, M., Chida, S., Tezuka, H., Hara, H., Sasaki, T., Ohteki, T., Ranieri, V. M., dos Santos, C. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0508oc · Cited by 289
Habibi, M. S., Jozwik, A., Makris, S., Dunning, J., Paras, A., DeVincenzo, J. P., de Haan, C. A. M., Wrammert, J., Openshaw, P. J. M., & Chiu, C. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201412-2256oc · Cited by 287
Stapleton, N. M., Andersen, J. T., Stemerding, A. M., Bjarnarson, S. P., Verheul, R. C., Gerritsen, J., Zhao, Y., Kleijer, M., Sandlie, I., de Haas, M., et al. (2011) · Nature Communications · doi:10.1038/ncomms1608 · Cited by 286
Salmon, J. E., Edberg, J. C., Brogle, N. L., & Kimberly, R. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115712 · Cited by 280
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
Johnson, S. M., McNally, B. A., Ioannidis, I., Flano, E., Teng, M. N., Oomens, A. G., Walsh, E. E., & Peeples, M. E. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005318 · Cited by 279
van de Geijn, F. E., Wuhrer, M., Selman, M. H., Willemsen, S. P., de Man, Y. A., Deelder, A. M., Hazes, J. M., & Dolhain, R. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2892 · Cited by 274
Baum, L. L., Cassutt, K. J., Knigge, K., Khattri, R., Margolick, J., Rinaldo, C., Kleeberger, C. A., Nishanian, P., Henrard, D. R., & Phair, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2168 · Cited by 271
Murphy, B. R., Sotnikov, A. V., Lawrence, L. A., Banks, S. M., & Prince, G. A. (1990) · Vaccine · doi:10.1016/0264-410x(90)90253-i · Cited by 271
Henry Dunand, C. J., Leon, P. E., Huang, M., Choi, A., Chromikova, V., Ho, I. Y., Tan, G. S., Cruz, J., Hirsh, A., Zheng, N.-Y., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.014 · Cited by 268
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Ackerman, M. E., Mikhailova, A., Brown, E. P., Dowell, K. G., Walker, B. D., Bailey-Kellogg, C., Suscovich, T. J., & Alter, G. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005315 · Cited by 258
Fc receptors in antibody‐dependent enhancement of viral infections
Taylor, A., Foo, S., Bruzzone, R., Vu Dinh, L., King, N. J. C., & Mahalingam, S. (2015) · Immunological Reviews · doi:10.1111/imr.12367 · Cited by 255
Pone, E. J., Zhang, J., Mai, T., White, C. A., Li, G., Sakakura, J. K., Patel, P. J., Al-Qahtani, A., Zan, H., Xu, Z., et al. (2012) · Nature Communications · doi:10.1038/ncomms1769 · Cited by 250
Dhodapkar, K. M., Kaufman, J. L., Ehlers, M., Banerjee, D. K., Bonvini, E., Koenig, S., Steinman, R. M., Ravetch, J. V., & Dhodapkar, M. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500014102 · Cited by 241
Gilman, M. S. A., Castellanos, C. A., Chen, M., Ngwuta, J. O., Goodwin, E., Moin, S. M., Mas, V., Melero, J. A., Wright, P. F., Graham, B. S., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaj1879 · Cited by 238
Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes
Hebell, T., Ahearn, J. M., & Fearon, D. T. (1991) · Science · doi:10.1126/science.1718035 · Cited by 237
Zeitlin, L., Pettitt, J., Scully, C., Bohorova, N., Kim, D., Pauly, M., Hiatt, A., Ngo, L., Steinkellner, H., Whaley, K. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108360108 · Cited by 229
Khurana, S., Loving, C. L., Manischewitz, J., King, L. R., Gauger, P. C., Henningson, J., Vincent, A. L., & Golding, H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006366 · Cited by 223
Junttila, T. T., Parsons, K., Olsson, C., Lu, Y., Xin, Y., Theriault, J., Crocker, L., Pabonan, O., Baginski, T., Meng, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3704 · Cited by 221
SHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis
Pearse, R. N., Kawabe, T., Bolland, S., Guinamard, R., Kurosaki, T., & Ravetch, J. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80074-6 · Cited by 219
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Gunn, B. M., Yu, W.-H., Karim, M. M., Brannan, J. M., Herbert, A. S., Wec, A. Z., Halfmann, P. J., Fusco, M. L., Schendel, S. L., Gangavarapu, K., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.07.009 · Cited by 218
Jegaskanda, S., Job, E. R., Kramski, M., Laurie, K., Isitman, G., de Rose, R., Winnall, W. R., Stratov, I., Brooks, A. G., Reading, P. C., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201574 · Cited by 215
Saphire, E. O., Schendel, S. L., Fusco, M. L., Gangavarapu, K., Gunn, B. M., Wec, A. Z., Halfmann, P. J., Brannan, J. M., Herbert, A. S., Qiu, X., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.033 · Cited by 212
Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy
Rook, G. A. W., Steele, J., Brealey, R., Whyte, A., Isenberg, D., Sumar, N., Nelson, J. L., Bodman, K. B., Young, A., Roitt, I. M., et al. (1991) · Journal of Autoimmunity · doi:10.1016/0896-8411(91)90173-a · Cited by 211
Welliver, R. C., Sun, M., Rinaldo, D., & Ogra, P. L. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80692-8 · Cited by 208
Immune correlates of vaccine protection against HIV-1 acquisition
Corey, L., Gilbert, P. B., Tomaras, G. D., Haynes, B. F., Pantaleo, G., & Fauci, A. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7732 · Cited by 205
Connors, M., Collins, P. L., Firestone, C. Y., & Murphy, B. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1634-1637.1991 · Cited by 203
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Wang, T. T., Maamary, J., Tan, G. S., Bournazos, S., Davis, C. W., Krammer, F., Schlesinger, S. J., Palese, P., Ahmed, R., & Ravetch, J. V. (2015) · Cell · doi:10.1016/j.cell.2015.06.026 · Cited by 201
Welliver, R. C., Kaul, T. N., & Ogra, P. L. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032103 · Cited by 192
IgG subclass distribution of antibodies to bacterial and viral antigens
FERRANTE, A., BEARD, L. J., & FELDMAN, R. G. (1990) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199008001-00004 · Cited by 190
Chu, H. Y., Steinhoff, M. C., Magaret, A., Zaman, K., Roy, E., Langdon, G., Formica, M. A., Walsh, E. E., & Englund, J. A. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu316 · Cited by 187
Fcγ Receptor Function and the Design of Vaccination Strategies
Bournazos, S., & Ravetch, J. V. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.009 · Cited by 185
He, W., Tan, G. S., Mullarkey, C. E., Lee, A. J., Lam, M. M. W., Krammer, F., Henry, C., Wilson, P. C., Ashkar, A. A., Palese, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609316113 · Cited by 182
Walsh, E. E., & Falsey, A. R. (2004) · The Journal of Infectious Diseases · doi:10.1086/421524 · Cited by 180
Cutting Edge: Biasing Immune Responses by Directing Antigen to Macrophage Fcγ Receptors
Anderson, C. F., & Mosser, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3697 · Cited by 178
Wang, D., Cummins, C., Bayliss, S., Sandercock, J., & Burls, A. (2008) · Health Technology Assessment · doi:10.3310/hta12360 · Cited by 175
Amigorena, S., Salamero, J., Davoust, J., Fridman, W. H., & Bonnerot, C. (1992) · Nature · doi:10.1038/358337a0 · Cited by 174
Welliver, R. C., & Duffy, L. (1993) · Pediatric Pulmonology · doi:10.1002/ppul.1950150104 · Cited by 171
Hussell, T., & Openshaw, P. J. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-11-2593 · Cited by 170
Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors
Geoghegan, S., Erviti, A., Caballero, M. T., Vallone, F., Zanone, S. M., Losada, J. V., Bianchi, A., Acosta, P. L., Talarico, L. B., Ferretti, A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201603-0658oc · Cited by 168
He, W., Chen, C.-J., Mullarkey, C. E., Hamilton, J. R., Wong, C. K., Leon, P. E., Uccellini, M. B., Chromikova, V., Henry, C., Hoffman, K. W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00928-3 · Cited by 166
Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
Mahan, A. E., Jennewein, M. F., Suscovich, T. J., Dionne, K., Tedesco, J., Chung, A. W., Streeck, H., Pau, M. G., Schuitemaker, H., Francis, D., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005456 · Cited by 163
HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions
Nelson, C. S., Huffman, T., Jenks, J. A., Cisneros de la Rosa, E., Xie, G., Vandergrift, N., Pass, R. F., Pollara, J., & Permar, S. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800177115 · Cited by 161
Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets
Bakalar, M. H., Joffe, A. M., Schmid, E. M., Son, S., Podolski, M., & Fletcher, D. A. (2018) · Cell · doi:10.1016/j.cell.2018.05.059 · Cited by 160
Functional and clinical consequences of Fc receptor polymorphic and copy number variants
Bournazos, S., Woof, J. M., Hart, S. P., & Dransfield, I. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03980.x · Cited by 157
Wu, Y., Cho, M., Shore, D. A., Song, M., Choi, J.-A., Jiang, T., Deng, Y., Bourgeois, M. A., Almli, L. M., Yang, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8708 · Cited by 152
Forthal, D. N., Gach, J. S., Landucci, G., Jeż, J., Strasser, R., Kunert, R., & Steinkellner, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002600 · Cited by 145
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
Bradley, T., Pollara, J., Santra, S., Vandergrift, N., Pittala, S., Bailey‐Kellogg, C., Shen, X., Parks, R., Goodman, D. D., Eaton, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15711 · Cited by 143
Dhodapkar, K. M., Banerjee, D. K., Connolly, J., Kukreja, A., Matayeva, E., Veri, M. C., Ravetch, J. V., Steinman, R. M., & Dhodapkar, M. V. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062545 · Cited by 141
Capella, C., Chaiwatpongsakorn, S., Gorrell, E., Risch, Z. A., Ye, F., Mertz, S. E., Johnson, S. M., Moore‐Clingenpeel, M., Ramilo, O., Mejías, A., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix489 · Cited by 139
The era of the immunoglobulin A Fc receptor Fcα RI ; its function and potential as target in disease
Aleyd, E., Heineke, M. H., & van Egmond, M. (2015) · Immunological Reviews · doi:10.1111/imr.12337 · Cited by 137
Tay, M. Z., Liu, P., Williams, L. D., McRaven, M. D., Sawant, S. S., Gurley, T. C., Xu, T. T., Dennison, S. M., Liao, H., Chenine, A., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005817 · Cited by 136
Vogt, M. R., Dowd, K. A., Engle, M. J., Tesh, R. B., Johnson, S., Pierson, T. C., & Diamond, M. (2011) · Journal of Virology · doi:10.1128/jvi.05859-11 · Cited by 134
Haynes, L. M., Caidi, H., Radu, G. U., Miao, C., Harcourt, J. L., Tripp, R. A., & Anderson, L. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/600108 · Cited by 133
Dalle, S., Reslan, L., de Horts, T. B., Herveau, S., Herting, F., Pleșa, A., Friess, T., Umaña, P., Klein, C., & Dumontet, C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0385 · Cited by 131
Falloon, J., Yu, J. H., Esser, M. T., Villafana, T. L., Li, Y., Dubovsky, F., Takas, T., Levin, M. J., & Falsey, A. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix503 · Cited by 131
Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms
Cleary, K. L. S., Chan, H. T. C., James, S., Glennie, M. J., & Cragg, M. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601473 · Cited by 130
Alternative complement pathway deregulation is correlated with dengue severity
Nascimento, E. J. M., Silva, A. M., Cordeiro, M. T., Brito, C. A., Gil, L. H. V. G., Braga-Neto, U., & Marques, E. T. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006782 · Cited by 124 · cited 1×
“In contrast, complement activation has also been suggested to contribute to disease severity in dengue virus (86, 87) and HIV infection (88, 89).”
BackgroundStensballe, L. G., Ravn, H., Kristensen, K., Agerskov, K., Meakins, T., Aaby, P., & Simões, E. A. F. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.043 · Cited by 123
Larrañaga, C. L., Ampuero, S., Luchsinger, V., Carrión, F., Aguilar, N. V., Morales, P., Palomino, M. A., Tapia, L. F., & Avendaño, L. F. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a3ea71 · Cited by 119
Hiatt, A., Bohorova, N., Bohorov, O., Goodman, C. A., Kim, D., Pauly, M. H., Velasco, J., Whaley, K. J., Piedra, P. A., Gilbert, B. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402458111 · Cited by 118
Li, F., Zhu, H., Sun, R., Wei, H., & Tian, Z. (2011) · Journal of Virology · doi:10.1128/jvi.06209-11 · Cited by 114
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Li, S. S., Gilbert, P. B., Tomaras, G. D., Kijak, G. H., Ferrari, G., Thomas, R., Pyo, C., Zolla‐Pazner, S., Montefiori, D. C., Liao, H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75539 · Cited by 114
Mehlhop, E., Nelson, S., Jost, C. A., Gorlatov, S. N., Johnson, S., Fremont, D. H., Diamond, M., & Pierson, T. C. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.09.003 · Cited by 112
Mousa, J. J., Kose, N., Matta, P., Gilchuk, P., & Crowe, J. E. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.271 · Cited by 111
Baraniak, I., Kropff, B., Ambrose, L. R., McIntosh, M., McLean, G. R., Pichon, S., Atkinson, C. E., Milne, R. S. B., Mach, M., Griffiths, P. D., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800224115 · Cited by 111
Atypical Measles and Enhanced Respiratory Syncytial Virus Disease (ERD) Made Simple
Polack, F. P. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180686ce0 · Cited by 106
Murphy, B. R., Sotnikov, A. V., Paradiso, P. R., Hildreth, S. W., Jenson, A. B., Baggs, R. B., LAWRENCE, L., Zubak, J., Chanock, R. M., & Beeler, J. A. (1989) · Vaccine · doi:10.1016/0264-410x(89)90278-8 · Cited by 105
Jegaskanda, S., Luke, C. J., Hickman, H. D., Sangster, M. Y., Wieland‐Alter, W., McBride, J., Yewdell, J. W., Wright, P. F., Treanor, J. J., Rosenberger, C. M., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw262 · Cited by 99
Mascola, J. R., Mathieson, B. J., Zack, P. M., Walker, M. C., Halstead, S. B., & Burke, D. S. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1175 · Cited by 96
Tripp, R. A., Moore, D. D., Barskey, A. E., Jones, L. P., Moscatiello, C., KEYSERLING, H. L., & Anderson, L. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/340505 · Cited by 93
Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.
McCullough, K. C., Parkinson, D., & Crowther, J. R. (1988) · PubMed · Cited by 91
Liu, Q., Fan, C., Li, Q., Zhou, S., Huang, W., Wang, L., Sun, C., Wang, M., Wu, X., Ma, J., et al. (2017) · Scientific Reports · doi:10.1038/srep45552 · Cited by 87
Chu, H. Y., Tielsch, J. M., Katz, J., Magaret, A., Khatry, S. K., LeClerq, S. C., Shrestha, L., Kuypers, J. M., Steinhoff, M. C., & Englund, J. A. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.08.017 · Cited by 84
Dakhama, A., Lee, Y. M., Ohnishi, H., Jing, X., Balhorn, A., Takeda, K., & Gelfand, E. W. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.012 · Cited by 83
Fuentes, S., Coyle, E. M., Beeler, J. A., Golding, H., & Khurana, S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005554 · Cited by 82
Systems serology for evaluation of HIV vaccine trials
Ackerman, M. E., Barouch, D. H., & Alter, G. (2017) · Immunological Reviews · doi:10.1111/imr.12503 · Cited by 81
Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies
Fedechkin, S. O., George, N. L., Wolff, J., Kauvar, L. M., & DuBois, R. M. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar3534 · Cited by 81
Respiratory syncytial virus and neutrophil activation
Bataki, E., EVANS, G. S., & Everard, M. L. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02780.x · Cited by 80
Miao, C., Radu, G. U., Caidi, H., Tripp, R. A., Anderson, L. J., & Haynes, L. M. (2009) · Journal of General Virology · doi:10.1099/vir.0.009308-0 · Cited by 77
Shim, H. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.10.063 · Cited by 77
Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem
Tripp, R. A., Power, U. F., Openshaw, P., & Kauvar, L. M. (2017) · Journal of Virology · doi:10.1128/jvi.01302-17 · Cited by 77
Boyoglu-Barnum, S., Todd, S. O., Chirkova, T., Barnum, T. R., Gaston, K. A., Haynes, L. M., Tripp, R. A., Moore, M. L., & Anderson, L. J. (2015) · Virology · doi:10.1016/j.virol.2015.02.035 · Cited by 74
Antibody-dependent cellular cytotoxicity and influenza virus
Vanderven, H. A., Jegaskanda, S., Wheatley, A. K., & Kent, S. J. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.12.002 · Cited by 74
Schneider-Ohrum, K., Cayatte, C., Bennett, A. S., Rajani, G. M., McTamney, P. M., Nacel, K., Hostetler, L., Cheng, L., Ren, K., O’Day, T. L., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02180-16 · Cited by 72
Cortjens, B., Yasuda, E., Xiao, Y., Wagner, K., Claassen, Y. B., Bakker, A. Q., van Woensel, J. B. M., & Beaumont, T. (2017) · Journal of Virology · doi:10.1128/jvi.02357-16 · Cited by 72
Targeting the Fc receptor in autoimmune disease
Li, X., & Kimberly, R. P. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.877891 · Cited by 71
Benhnia, M. R., McCausland, M. M., Laudenslager, J., Granger, S. W., Rickert, S., Koriazova, L. K., Tahara, T., Kubo, R. T., Kato, S., & Crotty, S. (2009) · Journal of Virology · doi:10.1128/jvi.01593-09 · Cited by 71
Eick, A. A., Karron, R. A., Shaw, J., et al. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815ac585 · Cited by 70
van Egmond, M., Vidarsson, G., & Bakema, J. E. (2015) · Immunological Reviews · doi:10.1111/imr.12333 · Cited by 69
Wagner, D. K., Muelenaer, P. M., Henderson, F. W., Snyder, M. H., Reimer, C. B., Walsh, E. E., Anderson, L. J., Nelson, D. L., & Murphy, B. R. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.3.589-592.1989 · Cited by 69
Krilov, L. R., Anderson, L. J., Marcoux, L., Bonagura, V. R., & Wedgwood, J. F. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.5.777 · Cited by 69
Moraru, M., Black, L. E., Muntasell, A., Portero, F., López‐Botet, M., Reyburn, H. T., Pandey, J. P., & Vilches, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500872 · Cited by 69
Bukreyev, A. A., Yang, L., & Collins, P. L. (2012) · Journal of Virology · doi:10.1128/jvi.01162-12 · Cited by 68
Influenza-Specific Antibody-Dependent Phagocytosis
Ana‐Sosa‐Batiz, F., Vanderven, H. A., Jegaskanda, S., Johnston, A. P. R., Rockman, S. P., Laurie, K., Barr, I., Reading, P. C., Lichtfuss, M., & Kent, S. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154461 · Cited by 66
Goodier, M. R., Lusa, C., Sherratt, S., Rodríguez‐Galán, A., Behrens, R. H., & Riley, E. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00384 · Cited by 63
Boyoglu-Barnum, S., Chirkova, T., Todd, S. O., Barnum, T. R., Gaston, K. A., Jorquera, P. A., Haynes, L. M., Tripp, R. A., Moore, M. L., & Anderson, L. J. (2014) · Journal of Virology · doi:10.1128/jvi.01503-14 · Cited by 61
Bera, M. M., Lu, B., Martin, T. R., Cui, S., Rhein, L. M., Gerard, C. J., & Gerard, N. P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101789 · Cited by 60
Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis
Kerrin, A., Fitch, P. M., Errington, C., Kerr, D., Waxman, L., Riding, K., McCormack, J. G., Mehendele, F., McSorley, H. J., Mackenzie, K. J., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207358 · Cited by 60
Faden, H., Kaul, T. N., & Ogra, P. L. O. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/148.1.110 · Cited by 59
Complement-Dependent Transport of Antigen into B Cell Follicles
González, S., Lukacs‐Kornek, V., Kuligowski, M., Pitcher, L. A., Degn, S. E., Turley, S. J., & Carroll, M. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000522 · Cited by 58
Antiviral Antibodies Target Adenovirus to Phagolysosomes and Amplify the Innate Immune Response
Zaiss, A. K., Vilaysane, A., Cotter, M. J., Clark, S. A., Meijndert, H. C., Colarusso, P., Yates, R. M., Pétrilli, V., Tschopp, J., & Muruve, D. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804269 · Cited by 58
Schepens, B., Sedeyn, K., Ginste, L. V., Baets, S. D., Schotsaert, M., Roose, K., Houspie, L., Ranst, M. A. V., Gilbert, B. E., van Rooijen, N., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404005 · Cited by 58
Brand, H. K., Ferwerda, G., Preijers, F. W. M. B., de Groot, R., Neeleman, C., Staal, F. J. T., Warris, A., & Hermans, P. W. M. (2012) · Pediatric Research · doi:10.1038/pr.2012.163 · Cited by 55
Self-citationMejías, A., García-Mauriño, C., Fernández, R. R., Peeples, M. E., & Ramilo, O. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.026 · Cited by 55
Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination
Forthal, D. N., Gabriel, E. E., Wang, A. Y., Landucci, G., & Phan, T. B. (2012) · Blood · doi:10.1182/blood-2012-05-431361 · Cited by 54
Schijf, M. A., Lukens, M. V., Kruijsen, D., van Uden, N. O. P., Garssen, J., Coenjaerts, F. E. J., Land, B. V., & van Bleek, G. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081695 · Cited by 52
Russi, J., Delfraro, A., Borthagaray, M. D., Velazquez, B., García‐Barreno, B., & Hortal, M. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.819-823.1993 · Cited by 50
Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection
Jounai, N., Yoshioka, M., Tozuka, M., Inoue, K., Oka, T., Miyaji, K., Ishida, K., Kawai, N., Ikematsu, H., Kawakami, C., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.014 · Cited by 50
Fc functional antibodies in humans with severe H7N9 and seasonal influenza
Vanderven, H. A., Liu, L., Ana‐Sosa‐Batiz, F., Nguyen, T. H. O., Wan, Y., Wines, B. D., Hogarth, P. M., Tilmanis, D., Reynaldi, A., Parsons, M. S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92750 · Cited by 49
Li, F., Freed, D. C., Tang, A., Rustandi, R. R., Troutman, M. C., Espeseth, A. S., Zhang, N., An, Z., McVoy, M. A., Zhu, H., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0038-0 · Cited by 46
Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants.
Watt, P. J., Zardis, M., & Lambden, P. R. (1986) · PubMed Central · Cited by 44
Co, M. D. T., Terajima, M., Thomas, S. J., Jarman, R. G., Rungrojcharoenkit, K., Fernandez, S., Yoon, I., Buddhari, D., Cruz, J., & Ennis, F. A. (2014) · Viral Immunology · doi:10.1089/vim.2014.0061 · Cited by 44
Plotkin, S. A., & Gilbert, P. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00003-1 · Cited by 43
Tregoning, J. S., Wang, B. L., McDonald, J. U., Yamaguchi, Y., Harker, J. A., Goritzka, M., Johansson, C., Bukreyev, A. A., Collins, P. L., & Openshaw, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214247110 · Cited by 42
Acosta, E. G., & Bartenschlager, R. F. W. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1121814 · Cited by 42
Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies
Gimenez, H. B., Chisholm, S. P., Dornan, J., & Cash, P. (1996) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.3.3.280-286.1996 · Cited by 41
An ultrastructural study of the interaction of human eosinophils with respiratory syncytial virus
Kimpen, J. L. L., Garofalo, R. P., Welliver, C., Fujihara, K., & Ogra, P. L. (1996) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.1996.tb00105.x · Cited by 40
Ye, Z., Yuan, S., Poon, V. K., Wen, L., Yang, D., Sun, Z., Li, C., Meng, H., Shuai, H., Zhou, J., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00317 · Cited by 40
van Erp, E. A., Feyaerts, D., Duijst, M., Mulder, H. L., Wicht, O., Luytjes, W., Ferwerda, G., & van Kasteren, P. B. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy566 · Cited by 37
Self-citationJans, J., Wicht, O., Widjaja, I., Ahout, I. M. L., de Groot, R., Guichelaar, T., Luytjes, W., de Jonge, M. I., de Haan, C. A. M., & Ferwerda, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170877 · Cited by 36
Self-citationMeguro, H., Kervina, M., & Wright, P. F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.6.2521 · Cited by 35
Guerrero-Plata, A., Ortega, E., & Gómez, B. (2001) · Viral Immunology · doi:10.1089/08828240151061347 · Cited by 35
Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants
Osiowy, C., Horne, D., & Anderson, R. (1994) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.6.670-677.1994 · Cited by 34
Long, X., Xie, J., Zhao, K., Li, W., Tang, W. X., Chen, S., Zang, N., Luo, R., Deng, Y., Xie, X., et al. (2016) · Medical Microbiology and Immunology · doi:10.1007/s00430-016-0459-9 · Cited by 32
Nyiro, J. U., Sande, C., Mutunga, M. N., Kiyuka, P. K., Munywoki, P. K., Scott, J. A. G., & Nokes, D. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166706 · Cited by 31
Melendi, G. A., Hoffman, S. J., Karron, R. A., Irusta, P. M., Laham, F. R., Humbles, A. A., Schofield, B., Pan, C.-H., Rabold, R., Thumar, B., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01783-06 · Cited by 28
Gómez, R. S., Ramírez, B., Céspedes, P. F., Cautivo, K. M., Riquelme, S. A., Prado, C. E., González, P. A., & Kalergis, A. M. (2015) · Immunology · doi:10.1111/imm.12541 · Cited by 28
IgE anti-respiratory syncytial virus antibodies detected in serum of pediatric patients with asthma
Smith-Norowitz, T. A., Mandal, M., Joks, R. O., Norowitz, L. T., Weaver, D., Durkin, H. G., Bluth, M. H., & Kohlhoff, S. A. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.06.002 · Cited by 26
Hu, X., Li, X., Hu, C., Qin, L., He, R., Luo, L., Tang, W. F., & Feng, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-15471-w · Cited by 26
Jacobino, S. R., Nederend, M., Reijneveld, J. F., Augustijn, D., Jansen, J. H. M., Meeldijk, J., Reiding, K. R., Wuhrer, M., Coenjaerts, F. E. J., Hack, C. E., et al. (2018) · mAbs · doi:10.1080/19420862.2018.1433974 · Cited by 26
Vieira, S. E., Gilio, A. E., Durigon, E. L., & Ejzenberg, B. (2007) · Clinics · doi:10.1590/s1807-59322007000600009 · Cited by 21
Gupta, N., LeGoff, J., Chamat, S., Mercier‐Delarue, S., Touzelet, O., Power, U. F., Kazatchkine, M. D., Simon, F., Lacroix‐Desmazes, S., Bayry, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069390 · Cited by 16
Cited by
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.044 · Cited by 1,016
The convalescent sera option for containing COVID-19
Casadevall, A., & Pirofski, L.-A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 903
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B., Winters, J. L., van Buskirk, C., Grossman, B. J., Joyner, M., Henderson, J. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138745 · Cited by 799
An Update on Current Therapeutic Drugs Treating COVID-19
Wu, R., Wang, L., Kuo, H.-C. D., Shannar, A., Peter, R., Chou, P. J., Li, S., Hudlikar, R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 599
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Arvin, A. M., Fink, K., Schmid, M. A., Cathcart, A., Spreafico, R., Havenar-Daughton, C., Lanzavecchia, A., Corti, D., & Virgin, H. W. (2020) · Nature · doi:10.1038/s41586-020-2538-8 · Cited by 485
Metadata
- Authors
- van Erp, E. A., Luytjes, W., Ferwerda, G., & van Kasteren, P. B.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-03-22
- Volume
- 10
- Pages
- 548-548
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2924905929
- Cited by
- 281
- References
- 185
- FWCI
- 26.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.